Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.71 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.71 |
| ▸ | FAAH | O00519 | 4/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.53 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.53 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.50 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15649018 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL15697666 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL2636226 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL9666571 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL9666565 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL25192254 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL9666953 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL7773487 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL9666963 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A | |
| SCHEMBL11804095 | 1.00 | PLA2G2A (0.71) | PLA2G2APLA2G5FAAHMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| US-11559071-B2 | N-acyl-amino acid derivatives for improvement of the flavour profile of edible compositions | GIVAUDAN SA (CH) | 2023-01-24 | — | — | US | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-11524933-B2 | In or relating to organic compounds | GIVAUDAN SA (CH) | 2022-12-13 | — | — | US | disclosed |
| CN-114569726-B | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-10-28 | — | — | CN | disclosed |
| CN-114788872-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114569726-A | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-06-03 | — | — | CN | disclosed |
| EP-0882702-A1 | Process for the preparation of N-acylaminoacids | LABORATOIRES ASEPTA (MC) | 1998-12-09 | — | — | EP | disclosed |
| US-5846790-A | Methods of producing L-lysine and L-glutamic acid by fermentation | AJINOMOTO CO., INC. (JP) | 1998-12-08 | — | — | US | disclosed |
| EP-0780477-A1 | PROCESS FOR PRODUCING L-LYSINE AND L-GLUTAMIC ACID BY FERMENTATION | Ajinomoto Co., Inc. (JP) | 1997-06-25 | — | — | EP | disclosed |
| EP-0721446-A1 | CHIRAL SURFACTANTS AND METHODS FOR THEIR USE IN CHIRAL SEPARATIONS | Waters Corporation (US) | 1996-07-17 | — | — | EP | disclosed |
| WO-1995008529-A1 | CHIRAL SURFACTANTS AND METHODS FOR THEIR USE IN CHIRAL SEPARATIONS | WATERS CORPORATION (US) | 1995-03-30 | — | — | WO | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
| US-4442090-A | ACYLATED AMINO ACID | KYOTO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1984-04-10 | — | — | US | disclosed |
| US-3971701-A | FATTY ACID, ESTER OR N-ACYLAMINO ACID SURFACTANT | AJINOMOTO CO., INC. (JA) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524933-B2 | In or relating to organic compounds | GABRB3, GABRB1, GABRB2 | PLA2G2A 4065/4885PLA2G5 4578/4885FAAH 1231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.